OneOncology Partners with Mid Florida Cancer Centers
Mid
Mid Florida Cancer Centers has been caring for the lives of Central Floridians for over 30 years, offering patients high quality, personalized healthcare close to their own home. Physicians engage in a team-based approach to healthcare, ensuring clinical collaboration, coordination, and communication with everyone in the patient's circle of care.
MFCC has nine medical oncologists, two radiation oncologists, and five advanced practice providers delivering oncology, hematology, and radiation therapy care services to patients at their four cancer centers. In addition to offering consultative services in blood and cancer diseases, and onsite infusion services, MFCC also offers an integrated in-house lab, oral dispensing pharmacy, radiation, and imaging services to its patients. MFCC is poised for growth by partnering with other independent oncology practices, adding services across the continuum of cancer care, and enhancing the practice's strong reputation with referring physicians as the high-value, low-cost cancer care provider in
"Our partnership with OneOncology gives us, and other oncology practices in
"We're excited about partnering with the physicians at Mid Florida Cancer Centers," said
About OneOncology
OneOncology was founded by community oncologists, for community oncologists, with the mission of improving the lives of everyone living with cancer. Our goal is to enable community oncology practices to remain independent and to improve patient access to care in their communities, all at a lower cost than in the hospital setting. OneOncology supports our platform of community oncology practices through group purchasing, operational optimization, practice growth, and clinical innovation. Our 1,000 cancer care providers care for approximately 615,000 patients at more than 339 sites of care nationwide. To learn more, visit oneoncology.com or LinkedIn.
View original content to download multimedia:https://www.prnewswire.com/news-releases/oneoncology-partners-with-mid-florida-cancer-centers-301982885.html
SOURCE OneOncology, LLC.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- FDA Grants Breakthrough Device Designation to Pharaoh Neuro's Neurapheresis™ CSF Management System
- IRELAND'S BIGGEST LEGS TO COMPETE FOR THE TITLE OF IRELAND'S KICKING KING, PRESENTED BY FM, AT THE NEW RYAN FIELD ON NOVEMBER 7
- YaraAmplix PROCOTE OPTIMIZE® and OPTITRAC® Biostimulants Now Commercially Available in the U.S.
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!





Tweet
Share